Literature DB >> 22041745

Identification of local clinical Candida isolates using CHROMagar Candida™ as a primary identification method for various Candida species.

P Madhavan1, F Jamal, P P Chong, K P Ng.   

Abstract

The objective of our study was to study the effectiveness of CHROMagar Candida™ as the primary identification method for various clinical Candida isolates, other than the three suggested species by the manufacturer. We studied 34 clinical isolates which were isolated from patients in a local teaching hospital and 7 ATCC strains. These strains were first cultured in Sabouraud dextrose broth (SDB) for 36 hours at 35ºC, then on CHROMagar plates at 30ºC, 35ºC and 37ºC. The sensitivity of this agar to identify Candida albicans, Candida dubliniensis, Candida tropicalis, Candida glabrata, Candida rugosa, Candida krusei and Candida parapsilosis ranged between 25 and 100% at 30ºC, 14% and 100% at 35ºC, 56% and 100% at 37ºC. The specificity of this agar was 100% at 30ºC, between 97% and 100% at 35ºC, 92% and 100% at 37ºC. The efficiency of this agar ranged between 88 and 100% at 30ºC, 83% and 100% at 35ºC, 88% and 100% at 37ºC. Each species also gave rise to a variety of colony colours ranging from pink to green to blue of different colony characteristics. Therefore, the chromogenic agar was found to be useful in our study for identifying clinical Candida isolates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22041745

Source DB:  PubMed          Journal:  Trop Biomed        ISSN: 0127-5720            Impact factor:   0.623


  9 in total

1.  Multicenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles.

Authors:  Ayman M Abdelhamed; Sean X Zhang; Tonya Watkins; Margie A Morgan; Fann Wu; Rebecca J Buckner; DeAnna D Fuller; Thomas E Davis; Hossein Salimnia; Marilynn R Fairfax; Paul R Lephart; Melinda D Poulter; Sarah B Regi; Michael R Jacobs
Journal:  J Clin Microbiol       Date:  2015-03-11       Impact factor: 5.948

2.  Comparative Study of the Effects of Fluconazole and Voriconazole on Candida glabrata, Candida parapsilosis and Candida rugosa Biofilms.

Authors:  Priya Madhavan; Farida Jamal; Chong Pei Pei; Fauziah Othman; Arunkumar Karunanidhi; Kee Peng Ng
Journal:  Mycopathologia       Date:  2018-01-29       Impact factor: 2.574

3.  COMPARISON BETWEEN FOUR USUAL METHODS OF IDENTIFICATION OF Candida SPECIES.

Authors:  Margarida Neves Souza; Stéfanie Otowicz Ortiz; Marcelo Martins Mello; Flávio de Mattos Oliveira; Luiz Carlos Severo; Cristine Souza Goebel
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jul-Aug       Impact factor: 1.846

4.  Identification of Candida species and susceptibility testing with Sensititre YeastOne microdilution panel to 9 antifungal agents.

Authors:  Emine Kucukates; Nuh N Gultekin; Zeynep Alisan; Nur Hondur; Recep Ozturk
Journal:  Saudi Med J       Date:  2016-07       Impact factor: 1.484

5.  Emergence of Vulvovaginal Candidiasis among Lebanese Pregnant Women: Prevalence, Risk Factors, and Species Distribution.

Authors:  Nahed Ghaddar; Ali El Roz; Ghassan Ghssein; José-Noel Ibrahim
Journal:  Infect Dis Obstet Gynecol       Date:  2019-07-28

6.  Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.

Authors:  Nahed Ghaddar; Elie Anastasiadis; Rawad Halimeh; Ali Ghaddar; Rita Dhar; Wadha AlFouzan; Hoda Yusef; Mira El Chaar
Journal:  BMC Infect Dis       Date:  2020-01-13       Impact factor: 3.090

7.  Candidemia in pediatric burn patients: Risk factors and outcomes in a retrospective cohort study.

Authors:  Behnam Sobouti; Mostafa Dahmardehei; Shahrzad Fallah; Majid Karrobi; Yaser Ghavami; Reza Vaghardoost
Journal:  Curr Med Mycol       Date:  2020-09

8.  Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp.

Authors:  Ana Rita Sokolonski; Maísa Santos Fonseca; Bruna Aparecida Souza Machado; Kathleen Ramos Deegan; Roberto Paulo Correia Araújo; Marcelo Andrés Umsza-Guez; Roberto Meyer; Ricardo W Portela
Journal:  BMC Complement Med Ther       Date:  2021-11-24

9.  Performance of Kiestra total laboratory automation combined with MS in clinical microbiology practice.

Authors:  Nico T Mutters; Caspar J Hodiamont; Menno D de Jong; Hendri P J Overmeijer; Mandy van den Boogaard; Caroline E Visser
Journal:  Ann Lab Med       Date:  2014-02-13       Impact factor: 3.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.